Jianmin Pharmaceutical GroupLtd's accrual ratio indicates su...

Moomoo AI Mar 23, 2024 07:34

Jianmin Pharmaceutical GroupLtd's accrual ratio indicates subpar cash conversion, potentially undermining its true earnings power. Despite this, its EPS has seen remarkable growth over the past three years. Investors should be aware of certain warning signs.

Jianmin Pharmaceutical GroupLtd's (SHSE:600976) Solid Profits Have Weak Fundamentals

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

3433 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

4952

Followers

Following

11K

Visitors